TOUCAN
DEAD

Serial Number

97822706

Owner

Touchlight IP Limited

Attorney

Rebecca Liebowitz

Filing Date

Mar 3, 2023

Add to watchlist:

No watchlists yet
View on USPTO

TOUCAN Trademark

Serial Number: 97822706

TOUCAN is a trademark filed by Touchlight IP Limited on March 3, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Touchlight IP Limited (15 trademarks)

Morelands And Riverdale Buildings

Entity Type: 99

Trademark Details

Filing Date

March 3, 2023

Registration Date

Not Registered

Goods & Services

Treatment of nucleic acid constructs; manufacture of nucleic acid constructs; manufacture of nucleic acids; manufacture of viruses; manufacture of vectors; manufacture of medical and veterinary therapies, vaccines, prophylactics and counteragents; consultancy relating to the aforesaid services

Apparatus and instruments for the manufacture and processing of nucleic acid constructs

Nucleic acid constructs for medical and veterinary purposes; nucleic acid constructs and vectors for use as prophylactic or therapeutic vaccines; nucleic acid constructs and vectors for the production of prophylactic or therapeutic vaccines; nucleic acid constructs and vectors for medical use; nucleic acid constructs and vectors for the production of therapeutic or prophylactic viruses; nucleic acid constructs and vectors for gene therapy; nucleic acid constructs and vectors for use in cell therapy; nucleic acid constructs and vectors for use in genome editing; nucleic acid constructs and vectors for use in therapy

Chemicals, enzymes, nucleic acid constructs and vectors for scientific and research use; nucleic acid constructs and vectors for use in the manufacture of nucleic acids; nucleic acid constructs and vectors for manufacturing viruses; nucleic acid constructs and vectors for use in scientific research

Scientific and technological services and research and design relating thereto; chemical and biological analysis and research services; research into nucleic acids and nucleic acid constructs; research and development into the creation of nucleic acid constructs; research, analysis, design and development relating to therapies, prophylactics and counteragents based on nucleic acid constructs; research and development in the fields of gene therapy and diagnostics; consultancy relating to the aforesaid services

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Apr 1, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Apr 1, 2024 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 7, 2023 GNRN
NON-FINAL ACTION E-MAILED
Dec 7, 2023 GNRT
NON-FINAL ACTION WRITTEN
Dec 7, 2023 CNRT
ASSIGNED TO EXAMINER
Dec 1, 2023 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Nov 13, 2023 AMPX
ASSIGNED TO LIE
Nov 13, 2023 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Jun 8, 2023 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 23, 2023 NWOS
NEW APPLICATION ENTERED
Mar 7, 2023 NWAP